What is he best known for?
The fields of study he is best known for:
His main research concerns Virology, Epitope, Antibody, Molecular biology and Glycoprotein.
John P. Moore combines topics linked to Immunology with his work on Virology.
His Epitope research is multidisciplinary, relying on both Protein structure, Viral replication and Glycan.
His Antibody study combines topics from a wide range of disciplines, such as Recombinant DNA and Antigen.
His Molecular biology research focuses on subjects like Lipid bilayer fusion, which are linked to Signal transduction.
His Glycoprotein research incorporates themes from Glycoprotein complex, Cleavage and Gp41.
His most cited work include:
- HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. (2945 citations)
- Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. (1033 citations)
- CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. (1013 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Virology, Antibody, Glycoprotein, Epitope and Virus.
He interconnects Immunology, Gp41 and Monoclonal antibody in the investigation of issues within Virology.
Many of his studies on Antibody involve topics that are commonly interrelated, such as Immune system.
His Glycoprotein study incorporates themes from Antigen, Immunogenicity and Recombinant DNA.
His work in Epitope tackles topics such as Glycan which are related to areas like Glycosylation.
His work in Virus covers topics such as CCR5 receptor antagonist which are related to areas like Vicriviroc.
He most often published in these fields:
- Virology (53.56%)
- Antibody (27.40%)
- Glycoprotein (26.51%)
What were the highlights of his more recent work (between 2012-2021)?
- Virology (53.56%)
- Antibody (27.40%)
- Glycoprotein (26.51%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Virology, Antibody, Glycoprotein, Epitope and Glycan.
His work is dedicated to discovering how Virology, Immunogenicity are connected with Viral protein and Molecular biology and other disciplines.
His Antibody research is multidisciplinary, incorporating perspectives in Virus and Immune system.
His Glycoprotein study integrates concerns from other disciplines, such as Biophysics, Immunogen, Recombinant DNA and Antigen.
The concepts of his Epitope study are interwoven with issues in Protein structure, Antigenicity and Monoclonal antibody.
His study in Glycan is interdisciplinary in nature, drawing from both Allosteric regulation, Glycosylation, Protomer and Lipid bilayer fusion.
Between 2012 and 2021, his most popular works were:
- Crystal structure of a soluble cleaved HIV-1 envelope trimer. (671 citations)
- A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies (623 citations)
- Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer (564 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Virology, Epitope, Glycoprotein, Antibody and Glycan.
Within one scientific family, John P. Moore focuses on topics pertaining to Immunogenicity under Virology, and may sometimes address concerns connected to Neutralizing antibody.
His research integrates issues of Protein structure, Molecular biology and Binding site in his study of Epitope.
His Glycoprotein research is multidisciplinary, incorporating elements of Immunogen, Hiv 1 envelope and Germline.
His Antibody study necessitates a more in-depth grasp of Immunology.
His biological study spans a wide range of topics, including Lipid bilayer fusion, Glycosylation, Cell biology, Computational biology and Allosteric regulation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
